Drugs Made In America Acquisition DMIIU
NASDAQ DMIIU
$10.20 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Drugs Made In America Acquisition II Corp. (DMIIU) Other Accumulated Expenses (2025)

Drugs Made In America Acquisition (DMIIU) posted quarterly Other Accumulated Expenses of $553748.0 for Q3 2025.

Drugs Made In America Acquisition II Corp. (DMIIU) Other Accumulated Expenses (2025) Analysis & Trends

Drugs Made In America Acquisition (DMIIU) has reported Other Accumulated Expenses for 1 consecutive years, with $553748.0 the latest figure, recorded in Q3 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Sep 30, 2025 553,748.00